Promoting Informed Choice for Breast Cancer Screening

Breast Cancer Clinical Trial

Official title: Understanding Affective Processing of Scientific Evidence to Promote Informed Choice for Breast Cancer Screening

Status Active, not recruiting

Clinical Trial Summary

Identify the prevalence and predictors of reactance, self-exemption, disbelief, source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and trust.

Clinical Trial Description

In this study, the goal is to identify the prevalence and predictors of reactance, self-exemption, disbelief, and source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and trust. Research has not yet systematically identified the proportion of women who respond negatively (vs. positively) to evidence about the benefits and harms of mammography screening, or attempted to explain these responses by examining theory-driven predictors. The Investigator will develop and conduct a probability-based nationally representative survey in which mammography evidence is communicated using current best practices in risk communication. The Investigators will identify theory-driven predictors of negative and positive responses to that evidence, and identify consequences of these responses for screening decision-making and trust. ;

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms

• NCT number: NCT05376241
• Study type: Observational
• Source: University of Colorado, Denver
• Status: Active, not recruiting
• Start date: August 7, 2020
• Completion date: May 2025